Keyphrases
Usual Care
100%
Impact on Patients
100%
Drug Treatment
100%
Revascularization
100%
Patient Survival
100%
Myocardial Infarction Patients
100%
Cardioprotective Drugs
100%
Pharmacological Treatment
37%
Myocardial Infarction
37%
Cardiovascular Survival
37%
Cardiovascular Disease
25%
Hospitalization
25%
Survival Rate
25%
Cardiovascular Mortality
25%
Regression Tree
25%
Cox Proportional Hazards Model
25%
Province of Québec
25%
Drug Class
25%
Randomized Controlled Trial
12%
Beta-blockers
12%
Control Intervention
12%
Model Regression
12%
Logistic Regression
12%
Rate of Increase
12%
Quebec
12%
Mortality Rate
12%
Randomized Clinical Trial
12%
Secondary Prevention
12%
Treatment Impact
12%
Comorbidity
12%
Statins
12%
Angiotensin-converting Enzyme Inhibitor (ACEi)
12%
Logistic Regression Analysis
12%
Dependant Variables
12%
Healthcare Management
12%
Comorbidity Index
12%
Cardioprotection
12%
Coronary Artery Bypass Grafting
12%
Percutaneous Transluminal Coronary Angioplasty
12%
Noncardiovascular Disease
12%
Selected Populations
12%
Acetylsalicylic Acid
12%
Tree Regression
12%
Time Since Death
12%
Regression Logistic
12%
ICD-9
12%
Kaplan-Meier Survival Curves
12%
Medicine and Dentistry
Myocardial Infarction
100%
Drug Therapy
100%
Revascularization
100%
Cardiovascular System
50%
Cardiovascular Disease
37%
Logistic Regression Analysis
25%
Comorbidity
25%
Population Research
25%
Proportional Hazards Model
25%
Survival Rate
25%
Randomized Controlled Trial
12%
Randomized Clinical Trial
12%
Secondary Prevention
12%
Mortality Rate
12%
Acetylsalicylic Acid
12%
Statin
12%
Kaplan Meier Method
12%
Cardiovascular Mortality
12%
Coronary Artery Bypass Graft
12%
Transluminal Coronary Angioplasty
12%
ICD-9
12%
ACE Inhibitor
12%
Beta Adrenergic Receptor Blocking Agent
12%
Pharmacological Treatment
12%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Infarction
100%
Pharmacotherapy
100%
Cardiovascular Disease
75%
Comorbidity
50%
Survival Rate
50%
Population Study
50%
Randomized Controlled Trial
25%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
25%
Mortality Rate
25%
Dipeptidyl Carboxypeptidase Inhibitor
25%
Acetylsalicylic Acid
25%
Randomized Clinical Trial
25%
Cardiovascular Mortality
25%
ICD-9
25%
Beta Adrenergic Receptor Blocking Agent
25%
Nursing and Health Professions
Heart Infarction
100%
Drug Therapy
100%
Revascularization
100%
Cardiovascular Disease
37%
Logistic Regression Analysis
25%
Comorbidity
25%
Proportional Hazards Model
25%
Survival Rate
25%
Secondary Prevention
12%
Mortality Rate
12%
Kaplan Meier Method
12%
Cardiovascular Mortality
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Coronary Artery Bypass Graft
12%
Alka-Seltzer
12%
Transluminal Coronary Angioplasty
12%
ICD-9
12%
Dipeptidyl Carboxypeptidase Inhibitor
12%
Beta Adrenergic Receptor Blocking Agent
12%